Delivery Order SPE2DR25D2212-SPE2DR26FB9TK
- Not listed
- The Defense Logistics Agency awarded a $2,277.36 delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 22, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by January 23, 2026. The work will be performed at Amerisourcebergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $3,594.48 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s, larger...
- The Defense Logistics Agency awarded a $3,081.23 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price contract, with a completion date of January 20, 2026, was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order valued at $6,442.68 to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price delivery order, with a completion date of January 28, 2026, represents a routine pharmaceutical procurement supporting military and federal healthcare operations. The award was competitively granted with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order valued at $7,198.93 to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This competitive award, structured as a firm fixed-price delivery order with no set-aside designation, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with a completion deadline of January 22, 2026. The contract represents a task order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (via its parent company Cencora, Inc.) on January 9, 2026, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $11,167.12 and an ultimate completion date of January 12, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The pharmaceutical distributor will perform this work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,023.31 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.15 mg auto-injector 2-packs. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 13, 2026, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $6,711.86 and firm fixed pricing. This non-set-aside, competitively awarded contract is scheduled for completion by November 4, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,955.63 on November 14, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award, and requires completion by November 17, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.04 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9TKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,317.74 to Amerisourcebergen Drug Corp (subsidiary of parent company Cencora, Inc.) on February 2, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This non-set-aside, competitively awarded contract features firm fixed-price pricing with an ultimate completion date of February 3, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. The epinephrine auto-injectors represent critical emergency medical supplies essential for treating severe allergic reactions and anaphylaxis across military healthcare systems. This delivery order is issued under Amerisourcebergen's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a global pharmaceutical support vehicle enabling the company to supply a broad spectrum of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. Amerisourcebergen's contract portfolio with DLA encompasses specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 2/1/26 |